Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

AACE: New Guidance on Insulin Pumps

In order for a patient to obtain maximum benefit from an insulin pump, uniform training programs must be developed.... 

Advertisement

George Grunberger, MD, president of AACE stated in an updated consensus statement that, "The organization acknowledges that pumps have become more sophisticated, and in order to obtain maximum benefit, training programs should be developed." According to that statement, which was published in Endocrine Practice, an update to earlier guidance from 2010 offered recommendations for patients who are on pump therapy with both type 1 and type 2 diabetes. It addresses the benefits of pump therapy, which include: pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.

The guidance provides an update on the state of technology and improvements to functional features of the pump. These improvements can be maximized if providers offer comprehensive training programs to patients.

Dr. Grunberger made several recommendations for creating a uniform training program including that the right people should be on the pumps and the people on pump therapy should be trained well. Some of the challenges in using pump therapy were also outlined including one of the biggest, that Medicare no longer covers CGM for pump therapy in patients over 65.

Practice Pearls:
  • Pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.
  • The guidance provides an update on the state of technology and improvements to functional features of the pump.
  • Medicare no longer covers CGM for pump therapy in patients over 65

Grunberger G, et al "Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force" Presented at the 2014 AACE meeting. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 29 May, 2014 and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

Past five issues: SGLT-2 Inhibitors Special Edition May 2015 | Diabetes Clinical Mastery Series Issue 242 | Issue 782 | GLP-1 Special Editions May 2015 | Diabetes Clinical Mastery Series Issue 241 |

2015 Most Popular Articles:

Neuropathy Due to Vitamin B-12 Deficiency, Not Diabetes
Posted April 30, 2015
What Is the Medicare Diabetes Prevention Act?
Posted May 08, 2015
Is Diet or Exercise the Best Way to Reduce Diabetes Risk?
Posted May 15, 2015
Fish Oil May Help with Diabetic Neuropathy
Posted May 15, 2015
GLP-1 Analog May Help with NAFLD and Nonalcoholic Steatohepatitis
Posted May 15, 2015
SGLT-2 Inhibitors: Teach from the Start and Manage Expectations
Posted May 03, 2015
Vitamin D Supplements May Help Patients Lose Weight
Posted May 15, 2015
Metformin Reported in Use with Only 3.7% of Those with Prediabetes
Posted April 30, 2015
Treating Sleep Apnea with CPAP Nightly Can Lower Diabetes Risk
Posted May 08, 2015
Summary of Standards of Care for Diabetes for Primary Care
Posted April 30, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you believe that the FDA takes too much time to approve a drug?
CME/CE of the Week
Vickie Driver, DPM, MS, FACFAS

Category: Wound Care
Credits: 1.0



Search Articles On Diabetes In Control